SCOTTSDALE, Ariz.--(BUSINESS WIRE)--March 14, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM) (FWB:S2U), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, has announced that its international laboratory and clinical licensee, the Institute for Cellular Medicine (ICM) in Costa Rica, has named Dr. Miguel Bedolla, an internationally recognized bioethics and public health expert, to its Ethical Advisory Board.
